blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2542687

EP2542687 - INVOLVEMENT OF ANDROGEN/ANDROGEN RECEPTOR PATHWAY IN FABRY DISEASE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  07.02.2014
Database last updated on 18.10.2024
Most recent event   Tooltip07.02.2014Application deemed to be withdrawnpublished on 12.03.2014  [2014/11]
Applicant(s)For all designated states
Baylor Research Institute
3310 Live Oak Street, Suite 501
Dallas, TX 75204 / US
[2013/02]
Inventor(s)01 / SHEN, Jinsong
208 Tuscany Court
Allen, TX 75013 / US
02 / SCHIFFMANN, Raphael
2125 Hillcroft Drive
Rockwall, TX 75087 / US
03 / MENG, Xingli
208 Tuscany Court
Allen, TX 75013 / US
 [2013/02]
Representative(s)SONN Patentanwälte GmbH & Co KG
Riemergasse 14
1010 Wien / AT
[N/P]
Former [2013/02]Sonn & Partner Patentanwälte
Riemergasse 14
1010 Wien / AT
Application number, filing date11751240.001.03.2011
WO2011US26761
Priority number, dateUS20100310802P05.03.2010         Original published format: US 310802 P
[2013/02]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011109448
Date:09.09.2011
Language:EN
[2011/36]
Type: A1 Application with search report 
No.:EP2542687
Date:09.01.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 09.09.2011 takes the place of the publication of the European patent application.
[2013/02]
Search report(s)International search report - published on:AU09.09.2011
ClassificationIPC:C12Q1/00, A61P3/00, G01N33/483, A61K38/00, A61P5/26, G01N33/487
[2013/02]
CPC:
G01N33/743 (EP,US); A61P3/00 (EP); A61P5/26 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/02]
Extension statesBA05.09.2012
ME05.09.2012
TitleGerman:BETEILIGUNG VON ANDROGEN/ANDROGENREZEPTORPFAD AN MODUS FABRY[2013/02]
English:INVOLVEMENT OF ANDROGEN/ANDROGEN RECEPTOR PATHWAY IN FABRY DISEASE[2013/02]
French:PARTICIPATION DE VOIE DE SIGNALISATION D'ANDROGÈNES/DU RÉCEPTEUR DES ANDROGÈNES DANS MALADIE DE FABRY[2013/02]
Entry into regional phase05.09.2012National basic fee paid 
05.09.2012Search fee paid 
05.09.2012Designation fee(s) paid 
05.09.2012Examination fee paid 
Examination procedure05.09.2012Amendment by applicant (claims and/or description)
05.09.2012Examination requested  [2013/02]
01.10.2013Application deemed to be withdrawn, date of legal effect  [2014/11]
29.10.2013Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2014/11]
Fees paidPenalty fee
Additional fee for renewal fee
31.03.201303   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO03086386  (NOVOGEN RES PTY LTD [AU], et al);
 [X]WO2008115719  (CURIS INC [US], et al);
 [XP]WO2010118330  (BAYLOR RES INST [US], et al);
 [A]  - HAUSER A.C. ET AL., "Hormonal profile and fertility in patients with Anderson-Fabry disease", INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, (2005), vol. 59, no. 9, pages 1025 - 1028, XP055096265

DOI:   http://dx.doi.org/10.1111/j.1742-1241.2005.00620.x
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.